Dr. Stephen Bekanich Joins BrainCheck as Chief Medical Officer

Audio By Carbonatix

AUSTIN, Texas & NEW YORK--(BUSINESS WIRE)--Mar 10, 2026--

BrainCheck Inc., a digital platform for cognitive assessment and care, today announced that Stephen Bekanich, M.D., has joined the company as Chief Medical Officer. In this role, Dr. Bekanich will lead BrainCheck’s clinical strategy and help expand its value-based and collaborative care initiatives as the company continues to scale nationally.

Dr. Bekanich brings decades of experience in geriatric medicine, palliative care, accountable care organizations, and health system leadership. Most recently, he co-founded and served as Chief Medical Officer of Iris Healthcare, a disease-specific advance care planning service focused on improving outcomes for patients with serious illness that was later acquired by Aledade in 2022. Previously, he served as CEO of Ascension Health’s Texas ACO and as Chief Medical Officer of the Cigna–Ascension Health insurance joint venture, where he led large-scale value-based care initiatives across diverse patient populations. He is the recipient of multiple awards recognizing excellence in medical leadership, healthcare innovation, teaching, and patient and family satisfaction.

“Dr. Bekanich has deep experience operating at the intersection of clinical care and risk management,” said Chris Loughlin, CEO of BrainCheck. “As cognitive impairment becomes an increasingly urgent priority for clinicians and health systems, his leadership will help us accelerate our clinical impact and further integrate BrainCheck into collaborative and value-based care frameworks.”

In his role as Chief Medical Officer at BrainCheck, Dr. Bekanich will focus on aligning BrainCheck’s platform with value-based and collaborative care frameworks, supporting the integration of cognitive assessment and care plan tools into coordinated, longitudinal management strategies.

“Health systems are increasingly accountable for outcomes, quality, and total cost of care, especially for complex, aging populations,” said Dr. Bekanich. “BrainCheck provides clinicians with actionable insights into cognitive health, and I’m excited to help expand how we integrate those insights into collaborative, value-based care models.”

Dr. Bekanich joins BrainCheck during a period of continued growth. In 2025, more than 150 new practices and health systems adopted BrainCheck, expanding the platform to over 500 practices nationwide and deepening partnerships with primary care groups, health systems, and value-based organizations.

For more information, visit www.braincheck.com.

About BrainCheck

BrainCheck is a clinically validated digital platform for cognitive assessment and care, anchored by BrainCheck Assess™—its flagship FDA Class II digital cognitive assessment. The platform delivers standardized, repeatable cognitive data across clinical and research settings.

BrainCheck is used by more than 500 healthcare organizations nationwide, including Bon Secours, UPMC, and Springfield Clinic, as well as 46 research hospitals, including The University of Texas at Austin and Stanford University. Clinicians use BrainCheck’s validated screeners and care planning tools to build tailored protocols, with more than 640,000 cognitive assessments and 14,000 Care Plans completed to date.

BrainCheck is intended to support clinical decision-making and is not designed to function as a stand-alone diagnostic tool.

View source version on businesswire.com:https://www.businesswire.com/news/home/20260310004385/en/

CONTACT: Media Contact

[email protected]

KEYWORD: TEXAS NEW YORK UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: MEDICAL DEVICES HEALTH TECHNOLOGY NEUROLOGY HEALTH TECHNOLOGY SOFTWARE

SOURCE: BrainCheck Inc.,

Copyright Business Wire 2026.

PUB: 03/10/2026 09:05 AM/DISC: 03/10/2026 09:06 AM

http://www.businesswire.com/news/home/20260310004385/en